247 related articles for article (PubMed ID: 32096178)
1. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
2. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
[No Abstract] [Full Text] [Related]
4. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
Zhu KR; Sun QF; Zhang YQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
[TBL] [Abstract][Full Text] [Related]
5. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
Chen ZH; Cui MY; Zhang HM
Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MIAT acts as an oncogene in Wilms' tumor through regulation of DGCR8.
Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10257-10263. PubMed ID: 31841180
[TBL] [Abstract][Full Text] [Related]
8. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
[TBL] [Abstract][Full Text] [Related]
9. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC01339 Hinders the Development of Wilms' Tumor via MiR-135b-3p/ADH1C Axis.
Yu Y; Liu Y
Horm Metab Res; 2024 Mar; 56(3):244-254. PubMed ID: 37890508
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 inhibits the growth, invasion and migration of Wilms' tumor via Wnt/β-catenin pathway.
Teng GY; Wang YJ; Geng M; Jiang ZP
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9899-9907. PubMed ID: 33090393
[TBL] [Abstract][Full Text] [Related]
13. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
Shen J; Shu Q
Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
15. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
Wang H; Zhang Y
Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive activity of Hnf1β in Wilms' tumor.
Liu Y; Kanyomse Q; Xie Y
Biosci Biotechnol Biochem; 2019 Nov; 83(11):2008-2015. PubMed ID: 31038395
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]